We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
-13.02%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.75%
AUM
$38.2B
AUM Growth
-$6.09B
(-14%)
Cap. Flow
+$114M
Cap. Flow
% of AUM
0.3%
Top 10 Holdings %
Top 10 Hldgs %
17.6%
Holding
1,625
New
564
Increased
379
Reduced
367
Closed
304
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI South Korea ETF
EWY
|
+$612M |
| 2 |
Intel
INTC
|
+$419M |
| 3 |
Walt Disney
DIS
|
+$322M |
| 4 |
Starbucks
SBUX
|
+$296M |
| 5 |
Citigroup
C
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BP
BP
|
+$564M |
| 2 |
Canadian National Railway
CNI
|
+$468M |
| 3 |
Microsoft
MSFT
|
+$465M |
| 4 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$455M |
| 5 |
Adobe
ADBE
|
+$375M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.68% |
| 2 | Financials | 18.85% |
| 3 | Technology | 17.88% |
| 4 | Consumer Discretionary | 11.66% |
| 5 | Industrials | 6.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Visa
V
$669B
| $785M | 2.06% |
5,952,940
-133,543
| -2% | -$18.4M |
|
2
Home Depot
HD
$324B
| $783M | 2.05% |
4,555,108
+232,419
| +5% | +$41.7M |
|
3
Bristol-Myers Squibb
BMY
$126B
| $767M | 2.01% |
14,764,859
+299,601
| +2% | +$16.1M |
|
4
Mastercard
MA
$469B
| $761M | 1.99% |
4,033,197
-375,378
| -9% | -$74.5M |
|
|
5
iShares MSCI South Korea ETF
EWY
$23.2B
| $662M | 1.73% |
11,242,764
+10,123,865
| +905% | +$612M |
|
6
AbbVie
ABBV
$454B
| $659M | 1.73% |
7,144,329
-1,918,859
| -21% | -$169M |
|
7
TJX Companies
TJX
$170B
| $642M | 1.68% |
14,354,504
+308,432
| +2% | +$15.6M |
|
|
8
Microsoft
MSFT
$2.83T
| $583M | 1.53% |
5,744,523
-4,338,458
| -43% | -$465M |
|
|
9
Adobe
ADBE
$84.3B
| $569M | 1.49% |
2,516,493
-1,551,936
| -38% | -$375M |
|
10
HCA Healthcare
HCA
$83.5B
| $507M | 1.33% |
4,070,469
-286,721
| -7% | -$38.5M |
|
11
Merck
MRK
$322B
| $466M | 1.22% |
6,391,715
+2,645,337
| +71% | +$187M |
|
12
TSMC
TSM
$2.16T
| $463M | 1.21% |
12,553,294
-1,106,261
| -8% | -$42.1M |
|
13
Biogen
BIIB
$29.6B
| $459M | 1.2% |
1,524,089
+94,227
| +7% | +$30.1M |
|
14
AstraZeneca
AZN
$261B
| $445M | 1.17% |
5,853,625
+3,021,635
| +107% | +$236M |
|
|
15
Intel
INTC
$504B
| $424M | 1.11% |
9,032,930
+8,958,730
| +12,074% | +$419M |
|
16
UnitedHealth
UNH
$385B
| $422M | 1.11% |
1,694,674
+727,540
| +75% | +$192M |
|
|
SHPG
17
DELISTED
Shire pic
SHPG
| $417M | 1.09% |
2,396,296
+997,198
| +71% | +$174M |
|
|
CELG
18
DELISTED
Celgene Corp
CELG
| $361M | 0.95% |
5,639,513
+1,490,823
| +36% | +$110M |
|
19
Automatic Data Processing
ADP
$97.1B
| $359M | 0.94% |
2,741,495
-1,810,505
| -40% | -$256M |
|
20
IBM
IBM
$195B
| $359M | 0.94% |
3,307,653
+1,375,441
| +71% | +$165M |
|
21
Union Pacific
UNP
$181B
| $336M | 0.88% |
2,430,893
-73,130
| -3% | -$10.8M |
|
22
GSK
GSK
$102B
| $325M | 0.85% |
6,804,768
+2,443,129
| +56% | +$120M |
|
23
Intuit
INTU
$77B
| $320M | 0.84% |
1,623,789
-1,530,519
| -49% | -$318M |
|
|
24
Walt Disney
DIS
$161B
| $314M | 0.82% |
2,859,493
+2,828,693
| +9,184% | +$322M |
|
25
Rio Tinto
RIO
$149B
| $308M | 0.81% |
6,345,450
+3,356,991
| +112% | +$164M |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2018 Portfolio in Review
As of Q4 2018, Arrowstreet Capital held 1,625 positions worth $38.2B, down 14% from $44.3B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital's Q4 2018 filing shows 564 new, 379 increased, 367 reduced and 304 closed positions. Its largest new stake was Starbucks: 4,733,289 shares worth $305M. The largest sale was BP, an estimated $564M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 18% a quarter earlier, followed by Financials and Technology.
- Arrowstreet Capital's largest Q4 2018 buy was Starbucks: 4,733,289 shares worth $305M.
- Arrowstreet Capital added most to iShares MSCI South Korea ETF in Q4 2018, an estimated $612M increase.
- Arrowstreet Capital's biggest Q4 2018 reduction was BP, cutting an estimated $564M.
- Arrowstreet Capital fully exited Royal Dutch Shell PLC ADS Class A in Q4 2018, selling an estimated $455M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $38.2B portfolio in Q4 2018.
- Arrowstreet Capital opened 564 new positions and closed 304 in Q4 2018.
- Arrowstreet Capital's portfolio value fell 14% quarter-over-quarter to $38.2B.
Based on Arrowstreet Capital's 13F filing for Q4 2018, filed 14 Feb 2019.